Ascribe announced the successful 'Go Live' and implementation of the company's Web Pharmacy solution at two hospital sites for East Lancashire Hospitals NHS Trust. One of which, Burnley General Hospital, was the first Ascribe Pharmacy customer in 1991.
GE Healthcare, the healthcare division of General Electric and Intel Corporation announced the creation of an evaluation lab in Israel in an effort to jointly test new technologies. The lab is located at the GE Healthcare premises in Tirat Carmel, in close proximity to the Intel R&D center in Haifa, with managers and employees from both companies leading the activities in the collaboration.
S3 Group, a global enabler of scalable chronic disease management programs, announced that Telbios, technical and service provider of Buongiorno CReG, Europe's largest chronic disease service, has chosen them to provide design and consultancy services to enable the launch of the service in four health trust areas of Milano, Como, Bergamo and Milano-2.
IBM (NYSE: IBM) has developed a unique new biomedical analytics platform for personalized medicine that will enable doctors to better advise on the best course of medical treatment. This will lead to smarter and more personalized healthcare in a wide-range of areas, including cancer management, hypertension, and AIDS care.
Appropriate procurement mechanisms, whereby small and medium sized enterprises (SMEs) have equal opportunities, innovation is stimulated, and Europe's market attractiveness and competitiveness upheld, can contribute significantly towards sustainable European healthcare systems, with safe, more efficient innovations being available to more people.
Parascript, LLC, an image analysis and pattern recognition technology provider, announced that its AccuDetect® Galileo computer-aided detection software for digital mammography showed better overall performance in detecting breast cancer in a recent retrospective study against iCad's SecondLook.